Biotech Showcase™ 2026 Brought Early-Stage Biotech Innovation to the Forefront During JPM Healthcare Week
SAN FRANCISCO–(BUSINESS WIRE)–As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology companies seeking meaningful visibility, strategic dialogue, and access to […]
BioFuture 2025 Returns to New York City October 13-15
New Therapeutic Spotlight Series Fosters Meaningful Dialogue Between Innovators, Industry Leaders, Investors, and Potential Partners NEW YORK–(BUSINESS WIRE)–In person and virtual registration is now open for Demy-Colton’s BioFuture™ conference, providing leading investors, […]
Seven Years After FDA Approval – Have CD19 CAR-T Cells Met Expectations?
Date: Wednesday, May 28th, 2025 Time: 11:00AM-12:00PM (ET) 11:00 – 11:05 am Introduction * Sara Demy, Founder & CEO, Demy-Colton* Steve Brozak, President and Co-founder, WBB Securities 11:05 – 11:10 am Understanding the […]
Rare disease therapeutic development facing challenges
Posted by Lisa Henderson on 03 March 2025 Industry experts point to a combination of factors negatively impacting the space, including IRA, funding, and market access concerns. 2024 heralded many investment deals, as […]
Neurodegenerative Disease Investment: Shifting Paradigms Beyond Amyloid And Tau
05 Mar 2025 By David Wild Companies are exploring new mechanisms of action beyond traditional amyloid and tau and both investors and big pharma are willing to make deals when […]
Biotech Showcase™ 2025: Innovation Insights for the Year Ahead
Biotech Showcase™ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media January 30, 2025 10:00 AM Eastern Standard Time […]